{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T15:22:33Z","timestamp":1793978553176,"version":"4.8.0"},"reference-count":80,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["ajo.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Ophthalmology"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1016\/j.ajo.2022.02.011","type":"journal-article","created":{"date-parts":[[2022,2,25]],"date-time":"2022-02-25T10:44:03Z","timestamp":1645785843000},"page":"79-98","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":49,"special_numbering":"C","title":["COVID-19 Vaccination and The Eye"],"prefix":"10.1016","volume":"240","author":[{"given":"Michael T.M.","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4311-859X","authenticated-orcid":false,"given":"Rachael L.","family":"Niederer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles N.J.","family":"McGhee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen V.","family":"Danesh-Meyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajo.2022.02.011_bib0001","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1001\/jama.2020.12839","article-title":"Pathophysiology, transmission, diagnosis, and treatment of Coronavirus disease 2019 (COVID-19): A review","volume":"324","author":"Wiersinga","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.ajo.2022.02.011_bib0002","series-title":"Coronavirus pandemic (COVID-19). Our world in data","author":"Ritchie","year":"2020"},{"key":"10.1016\/j.ajo.2022.02.011_bib0003","doi-asserted-by":"crossref","first-page":"n1343","DOI":"10.1136\/bmj.n1343","article-title":"Effect of the Covid-19 pandemic in 2020 on life expectancy across populations in the USA and other high income countries: simulations of provisional mortality data","volume":"373","author":"Woolf","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.ajo.2022.02.011_bib0004","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1016\/S0140-6736(20)32137-1","article-title":"SARS-CoV-2 immunity: review and applications to phase 3 vaccine candidates","volume":"396","author":"Poland","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.ajo.2022.02.011_bib0005","doi-asserted-by":"crossref","first-page":"e26","DOI":"10.1016\/S1473-3099(20)30773-8","article-title":"What defines an efficacious COVID-19 vaccine? A review of the challenges assessing the clinical efficacy of vaccines against SARS-CoV-2","volume":"21","author":"Hodgson","year":"2021","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ajo.2022.02.011_bib0006","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1001\/jama.2021.3199","article-title":"SARS-CoV-2 vaccines","volume":"325","author":"Creech","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.ajo.2022.02.011_bib0007","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","article-title":"Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine","volume":"383","author":"Polack","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajo.2022.02.011_bib0008","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJMoa2035389","article-title":"Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine","volume":"384","author":"Baden","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajo.2022.02.011_bib0009","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1056\/NEJMoa2101544","article-title":"Safety and efficacy of single-dose Ad26.COV2.S Vaccine against Covid-19","volume":"384","author":"Sadoff","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajo.2022.02.011_bib0010","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0140-6736(20)32661-1","article-title":"Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK","volume":"397","author":"Voysey","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.ajo.2022.02.011_bib0011","doi-asserted-by":"crossref","DOI":"10.1001\/jama.2021.15072","article-title":"Surveillance for adverse events after COVID-19 mRNA vaccination","author":"Klein","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.ajo.2022.02.011_bib0012","doi-asserted-by":"crossref","first-page":"6194","DOI":"10.1016\/j.vaccine.2020.07.013","article-title":"Planning for COVID-19 vaccines safety surveillance","volume":"38","author":"Kochhar","year":"2020","journal-title":"Vaccine"},{"key":"10.1016\/j.ajo.2022.02.011_bib0013","doi-asserted-by":"crossref","first-page":"n1931","DOI":"10.1136\/bmj.n1931","article-title":"Risk of thrombocytopenia and thromboembolism after Covid-19 vaccination and SARS-CoV-2 positive testing: self-controlled case series study","volume":"374","author":"Hippisley-Cox","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.ajo.2022.02.011_bib0014","doi-asserted-by":"crossref","DOI":"10.1001\/jama.2021.13443","article-title":"Myocarditis and pericarditis after vaccination for COVID-19","author":"Diaz","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.ajo.2022.02.011_bib0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.jns.2021.117532","article-title":"Clinical review of cerebral venous thrombosis in the context of COVID-19 vaccinations: Evaluation, management, and scientific questions","volume":"427","author":"Thakur","year":"2021","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.ajo.2022.02.011_bib0016","doi-asserted-by":"crossref","DOI":"10.1080\/09273948.2021.1976221","article-title":"Ocular adverse events after COVID-19 vaccination","author":"Ng","year":"2021","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.ajo.2022.02.011_bib0017","series-title":"Programme for International Drug Monitoring","year":"2020"},{"key":"10.1016\/j.ajo.2022.02.011_bib0018","unstructured":"Database of Adverse Event Notifications (DAEN). Canberra: Therapeutic Goods Administration (TGA), Australian Government Department of Health; 2021. Accessed Aug 31, 2021. https:\/\/www.tgagovau\/database-adverse-event-notifications-daen"},{"key":"10.1016\/j.ajo.2022.02.011_bib0019","unstructured":"Canada Vigilance adverse reaction database. Ottawa: Health Canada; 2021. Accessed Aug 31, 2021. https:\/\/www.canadaca\/en\/health-canada\/services\/drugs-health-products\/medeffect-canada\/adverse-reaction-databasehtml"},{"key":"10.1016\/j.ajo.2022.02.011_bib0020","series-title":"EudraVigilance: European database of suspected adverse drug reaction","year":"2021"},{"key":"10.1016\/j.ajo.2022.02.011_bib0021","unstructured":"Coronavirus (COVID-19) vaccine adverse reactions. London: Medicines and Healthcare Products Regulatory Agency, United Kingdom Department of Health and Social Care; 2021. Accessed Aug 31, 2021. https:\/\/www.govuk\/government\/publications\/coronavirus-covid-19-vaccine-adverse-reactions"},{"key":"10.1016\/j.ajo.2022.02.011_bib0022","unstructured":"Vaccine Adverse Event Reporting System (VAERS). Atlanta: Centers for Disease Control and Prevention, United States Department of Health and Human Services; 2021. Accessed Aug 31, 2021. https:\/\/wondercdcgov\/vaershtml"},{"key":"10.1016\/j.ajo.2022.02.011_bib0023","article-title":"Immunogenicity and safety of the BNT162b2 mRNA COVID-19 vaccine in adult patients with autoimmune inflammatory rheumatic diseases and in the general population: a multicentre study","author":"Furer","year":"2021","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.ajo.2022.02.011_bib0024","doi-asserted-by":"crossref","DOI":"10.1080\/09273948.2021.1962917","article-title":"Acute uveitis following COVID-19 vaccination","author":"ElSheikh","year":"2021","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.ajo.2022.02.011_bib0025","article-title":"Bilateral multifocal choroiditis following COVID-19 vaccination","author":"Goyal","year":"2021","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.ajo.2022.02.011_bib0026","doi-asserted-by":"crossref","DOI":"10.1097\/IAE.0000000000003277","article-title":"Uveitis following the BNT162b2 mRNA vaccination against SARS-CoV-2 infection: a possible association","author":"Rabinovitch","year":"2021","journal-title":"Retina"},{"key":"10.1016\/j.ajo.2022.02.011_bib0027","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1080\/09273948.2021.1949478","article-title":"Panuveitis following vaccination for COVID-19","volume":"29","author":"Mudie","year":"2021","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.ajo.2022.02.011_bib0028","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s12348-021-00251-5","article-title":"Reactivation of Vogt-Koyanagi-Harada disease under control for more than 6\u2009years, following anti-SARS-CoV-2 vaccination","volume":"11","author":"Papasavvas","year":"2021","journal-title":"J Ophthalmic Inflamm Infect"},{"key":"10.1016\/j.ajo.2022.02.011_bib0029","doi-asserted-by":"crossref","DOI":"10.1001\/jamaophthalmol.2021.3477","article-title":"Association of ocular adverse events with inactivated COVID-19 vaccination in patients in Abu Dhabi","author":"Pichi","year":"2021","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.ajo.2022.02.011_bib0030","first-page":"48","article-title":"Vaccine-associated uveitis","volume":"113","author":"Benage","year":"2016","journal-title":"Mo Med"},{"key":"10.1016\/j.ajo.2022.02.011_bib0031","article-title":"Herpes zoster following BNT162b2 mRNA Covid-19 vaccination in patients with autoimmune inflammatory rheumatic diseases: a case series","author":"Furer","year":"2021","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.ajo.2022.02.011_bib0032","first-page":"e16725","article-title":"Ipsilateral zoster ophthalmicus post COVID-19 vaccine in healthy young adults","volume":"13","author":"Thimmanagari","year":"2021","journal-title":"Cureus"},{"key":"10.1016\/j.ajo.2022.02.011_bib0033","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/S0140-6736(99)00623-6","article-title":"Reactivation of herpes virus infections after vaccinations?","volume":"353","author":"Walter","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.ajo.2022.02.011_bib0034","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2021-245792","article-title":"Reactivation of herpes simplex keratitis following vaccination for COVID-19","volume":"14","author":"Richardson-May","year":"2021","journal-title":"BMJ Case Reports"},{"key":"10.1016\/j.ajo.2022.02.011_bib0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.jfo.2021.06.001","article-title":"Acute corneal endothelial graft rejection following COVID-19 vaccination","author":"Crnej","year":"2021","journal-title":"J Fr Ophtalmol"},{"key":"10.1016\/j.ajo.2022.02.011_bib0036","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1136\/bjophthalmol-2021-319338","article-title":"Characteristics of endothelial corneal transplant rejection following immunisation with SARS-CoV-2 messenger RNA vaccine","volume":"105","author":"Phylactou","year":"2021","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ajo.2022.02.011_bib0037","article-title":"Corneal graft rejection following COVID-19 vaccine","author":"Rallis","year":"2021","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.ajo.2022.02.011_bib0038","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.4103\/ijo.IJO_1028_21","article-title":"Corneal graft rejection after COVID-19 vaccination","volume":"69","author":"Ravichandran","year":"2021","journal-title":"Indian J Ophthalmol"},{"key":"10.1016\/j.ajo.2022.02.011_bib0039","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1097\/ICO.0000000000002761","article-title":"Keratoplasty rejection after the BNT162b2 messenger RNA vaccine","volume":"40","author":"Wasser","year":"2021","journal-title":"Cornea"},{"key":"10.1016\/j.ajo.2022.02.011_bib0040","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.ijid.2021.07.035","article-title":"Anterior uveitis onset after bnt162b2 vaccination: is this just a coincidence?","volume":"110","author":"Renisi","year":"2021","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.ajo.2022.02.011_bib0041","article-title":"Corneal graft rejection after yellow fever vaccine: a case report","author":"Vignapiano","year":"2021","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.ajo.2022.02.011_bib0042","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/0002-9394(88)90588-0","article-title":"Corneal allograft rejection following immunization","volume":"106","author":"Steinemann","year":"1988","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajo.2022.02.011_bib0043","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1136\/bjo.2006.093187","article-title":"Corneal transplant rejection following influenza vaccination","volume":"90","author":"Wertheim","year":"2006","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ajo.2022.02.011_bib0044","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1038\/s41586-020-2814-7","article-title":"COVID-19 vaccine BNT162b1 elicits human antibody and T(H)1 T cell responses","volume":"586","author":"Sahin","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.ajo.2022.02.011_bib0045","doi-asserted-by":"crossref","first-page":"3983","DOI":"10.4049\/jimmunol.1600251","article-title":"Alloimmunity and tolerance in corneal transplantation","volume":"196","author":"Amouzegar","year":"2016","journal-title":"J Immunol"},{"key":"10.1016\/j.ajo.2022.02.011_bib0046","article-title":"Survey of corneal surgeons' attitudes regarding keratoplasty rejection risk associated with vaccinations","author":"Lockington","year":"2021","journal-title":"Cornea"},{"key":"10.1016\/j.ajo.2022.02.011_bib0047","doi-asserted-by":"crossref","DOI":"10.1001\/jamaophthalmol.2021.2471","article-title":"Bilateral acute macular neuroretinopathy after vaccination against SARS-CoV-2","volume":"139","author":"Book","year":"2021","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.ajo.2022.02.011_bib0048","article-title":"Acute macular neuroretinopathy following COVID-19 vaccination","author":"B\u00f8hler","year":"2021","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.ajo.2022.02.011_bib0049","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1080\/09273948.2021.1946567","article-title":"Acute macular neuroretinopathy following Coronavirus disease 2019 vaccination","volume":"29","author":"Mambretti","year":"2021","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.ajo.2022.02.011_bib0050","doi-asserted-by":"crossref","first-page":"490","DOI":"10.18502\/jovr.v16i3.9443","article-title":"COVID-19 recombinant mRNA vaccines and serious ocular inflammatory side effects: real or coincidence?","volume":"16","author":"Maleki","year":"2021","journal-title":"J Ophthalmic Vis Res"},{"key":"10.1016\/j.ajo.2022.02.011_bib0051","article-title":"Acute bilateral optic\/chiasm neuritis with longitudinal extensive transverse myelitis in longstanding stable multiple sclerosis following vector-based vaccination against the SARS-CoV-2","author":"Helmchen","year":"2021","journal-title":"J Neurol"},{"key":"10.1016\/j.ajo.2022.02.011_bib0052","doi-asserted-by":"crossref","DOI":"10.1080\/09273948.2021.1961815","article-title":"Acute thyroiditis and bilateral optic neuritis following SARS-CoV-2 vaccination with CoronaVac: a case report","author":"Leber","year":"2021","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.ajo.2022.02.011_bib0053","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21145021","article-title":"Differential effects of MS therapeutics on B cells - implications for their use and failure in AQP4-positive NMOSD patients","volume":"21","author":"Traub","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ajo.2022.02.011_bib0054","doi-asserted-by":"crossref","first-page":"85","DOI":"10.7224\/1537-2073.2018-104","article-title":"Case report: postvaccination anti-myelin oligodendrocyte glycoprotein neuromyelitis optica spectrum disorder: a case report and literature review of postvaccination demyelination","volume":"22","author":"Kumar","year":"2020","journal-title":"Int J MS Care"},{"key":"10.1016\/j.ajo.2022.02.011_bib0055","article-title":"COVID-19-induced acute bilateral optic neuritis","volume":"8","author":"Sawalha","year":"2020","journal-title":"J Investig Med High Impact Case Rep"},{"key":"10.1016\/j.ajo.2022.02.011_bib0056","doi-asserted-by":"crossref","first-page":"e25865","DOI":"10.1097\/MD.0000000000025865","article-title":"Myelin oligodendrocyte glycoprotein antibody-associated optic neuritis in a COVID-19 patient: A case report","volume":"100","author":"Kogure","year":"2021","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.ajo.2022.02.011_bib0057","first-page":"349","article-title":"Optic neuritis in a patient with seropositive myelin oligodendrocyte glycoprotein antibody during the post-COVID-19 period","volume":"14","author":"\u017dori\u0107","year":"2021","journal-title":"Int Med Case Rep J"},{"key":"10.1016\/j.ajo.2022.02.011_bib0058","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2020.102732","article-title":"Giant cell arteritis or polymyalgia rheumatica after influenza vaccination: A study of 12 patients and a literature review","volume":"20","author":"Liozon","year":"2021","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.ajo.2022.02.011_bib0059","doi-asserted-by":"crossref","DOI":"10.4084\/MJHID.2021.048","article-title":"A rare case of superior ophthalmic vein thrombosis and thrombocytopenia following ChAdOx1 nCoV-19 vaccine against SARS-CoV-2","volume":"13","author":"Panovska-Stavridis","year":"2021","journal-title":"Mediterr J Hematol Infect Dis"},{"key":"10.1016\/j.ajo.2022.02.011_bib0060","doi-asserted-by":"crossref","first-page":"e11","DOI":"10.1016\/S0140-6736(21)00872-2","article-title":"Bilateral superior ophthalmic vein thrombosis, ischaemic stroke, and immune thrombocytopenia after ChAdOx1 nCoV-19 vaccination","volume":"397","author":"Bayas","year":"2021","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.ajo.2022.02.011_bib0061","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1056\/NEJMoa2104882","article-title":"Thrombosis and thrombocytopenia after ChAdOx1 nCoV-19 vaccination","volume":"384","author":"Schultz","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajo.2022.02.011_bib0062","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1056\/NEJMoa2104840","article-title":"Thrombotic thrombocytopenia after ChAdOx1 nCov-19 vaccination","volume":"384","author":"Greinacher","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajo.2022.02.011_bib0063","doi-asserted-by":"crossref","first-page":"2170","DOI":"10.3324\/haematol.2021.279000","article-title":"Antibody-mediated procoagulant platelets in SARS-CoV-2-vaccination associated immune thrombotic thrombocytopenia","volume":"106","author":"Althaus","year":"2021","journal-title":"Haematologica"},{"key":"10.1016\/j.ajo.2022.02.011_bib0064","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/s41586-021-03744-4","article-title":"Antibody epitopes in vaccine-induced immune thrombotic thrombocytopaenia","volume":"596","author":"Huynh","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.ajo.2022.02.011_bib0065","first-page":"302","article-title":"Acute abducens nerve palsy following COVID-19 vaccination","volume":"25","author":"Reyes-Capo","year":"2021","journal-title":"JAAPOS"},{"key":"10.1016\/j.ajo.2022.02.011_bib0066","doi-asserted-by":"crossref","first-page":"301","DOI":"10.4161\/hv.27032","article-title":"Motor palsies of cranial nerves (excluding VII) after vaccination: reports to the US Vaccine Adverse Event Reporting System","volume":"10","author":"Woo","year":"2014","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.ajo.2022.02.011_bib0067","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1001\/archopht.1983.01040010607016","article-title":"Benign recurrent sixth nerve palsies in childhood. Secondary to immunization or viral illness","volume":"101","author":"Werner","year":"1983","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ajo.2022.02.011_bib0068","article-title":"Benign Recurrent sixth (abducens) nerve palsy following measles-mumps-rubella vaccination","volume":"2015","author":"Bourtoulamaiou","year":"2015","journal-title":"Case Rep Pediatr"},{"key":"10.1016\/j.ajo.2022.02.011_bib0069","first-page":"317","article-title":"Recurrent isolated sixth nerve palsy after consecutive annual influenza vaccinations in a child","volume":"13","author":"Leiderman","year":"2009","journal-title":"JAAPOS"},{"key":"10.1016\/j.ajo.2022.02.011_bib0070","first-page":"75","article-title":"Isolated abducens nerve palsy following neonatal hepatitis B vaccination","volume":"18","author":"Grewal","year":"2014","journal-title":"JAAPOS"},{"key":"10.1016\/j.ajo.2022.02.011_bib0071","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2021-243829","article-title":"Sequential contralateral facial nerve palsies following COVID-19 vaccination first and second doses","volume":"14","author":"Burrows","year":"2021","journal-title":"BMJ Case Rep"},{"key":"10.1016\/j.ajo.2022.02.011_bib0072","doi-asserted-by":"crossref","first-page":"3589","DOI":"10.1007\/s00415-021-10462-4","article-title":"Bell's palsy following COVID-19 vaccination","volume":"268","author":"Colella","year":"2021","journal-title":"J Neurol"},{"key":"10.1016\/j.ajo.2022.02.011_bib0073","first-page":"e15935","article-title":"Bell's palsy after 24 hours of mRNA-1273 SARS-CoV-2 vaccine","volume":"13","author":"Iftikhar","year":"2021","journal-title":"Cureus"},{"key":"10.1016\/j.ajo.2022.02.011_bib0074","first-page":"e17602","article-title":"Bilateral facial nerve palsy and COVID-19 vaccination: causation or coincidence?","volume":"13","author":"Mason","year":"2021","journal-title":"Cureus"},{"key":"10.1016\/j.ajo.2022.02.011_bib0075","article-title":"Bell's palsy following a single dose of mRNA SARS-CoV-2 vaccine: a case report","author":"Martin-Villares","year":"2021","journal-title":"J Neurol"},{"key":"10.1016\/j.ajo.2022.02.011_bib0076","article-title":"Bell's palsy after second dose of Pfizer COVID-19 vaccination in a patient with history of recurrent Bell's palsy","volume":"13","author":"Repajic","year":"2021","journal-title":"Brain Behav Immun Health"},{"key":"10.1016\/j.ajo.2022.02.011_bib0077","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.2147\/IJGM.S310497","article-title":"Minor to moderate side effects of Pfizer-BioNTech COVID-19 vaccine among Saudi residents: a retrospective cross-sectional study","volume":"14","author":"El-Shitany","year":"2021","journal-title":"Int J Gen Med"},{"key":"10.1016\/j.ajo.2022.02.011_bib0078","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1001\/jamaoto.2021.1259","article-title":"Association of COVID-19 vaccination and facial nerve palsy: a case-control study","volume":"147","author":"Shemer","year":"2021","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.ajo.2022.02.011_bib0079","article-title":"Bell's palsy following vaccination with mRNA (BNT162b2) and inactivated (CoronaVac) SARS-CoV-2 vaccines: a case series and nested case-control study","author":"Wan","year":"2021","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ajo.2022.02.011_bib0080","doi-asserted-by":"crossref","first-page":"361","DOI":"10.3389\/fpubh.2020.00361","article-title":"Do vaccines have a role as a cause of autoimmune neurological syndromes?","volume":"8","author":"Principi","year":"2020","journal-title":"Front Public Health"}],"container-title":["American Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939422000708?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939422000708?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T13:49:55Z","timestamp":1757598595000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002939422000708"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":80,"alternative-id":["S0002939422000708"],"URL":"https:\/\/doi.org\/10.1016\/j.ajo.2022.02.011","relation":{},"ISSN":["0002-9394"],"issn-type":[{"value":"0002-9394","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"COVID-19 Vaccination and The Eye","name":"articletitle","label":"Article Title"},{"value":"American Journal of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajo.2022.02.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}